Conference Coverage

Extended-release naltrexone helps alcohol-dependent HIV-positive prisoners transition to community


 

AT AIDS 2016

References

“We’ll never be able to end AIDS without addressing the needs of these most vulnerable individuals and communities, and yet we know in 2016 far too many are being left behind,” said Dr. Beyrer, professor of epidemiology at Johns Hopkins University, Baltimore.

Transgender individuals, for example, are 49 times more likely to have HIV infection than other adults. Injection drug users and men who have sex with men are each 24-fold more likely to become HIV infected than the general population. Sex workers are 10 times more likely to acquire HIV infection than others in their reproductive years. And prisoners have a fivefold greater prevalence of HIV.

“In 2014 these vulnerable groups accounted for more than one-third of all new HIV infections. That’s an extraordinary proportion of HIV,” he observed. “This truly is the undone work of the HIV response. If there’s any silver lining in this cloud, it’s this: We’re talking about a relatively small number of people who are at high risk of infection relative to the world’s population. And that means that turning this around doesn’t require massive new commitments to very large populations. What it does require is an honest acknowledgment of where the epidemic is hitting hardest and directing resources to that need.”

Unfortunately, screening and treatment programs are rarely tailored to reach these highly vulnerable groups effectively, he added.

Dr. Beyrer was a contributor to a special issue of the Lancet devoted to HIV infection among prisoners published with the AIDS 2016 conference.

Dr. Springer’s study was funded by the National Institute on Alcohol Abuse and Alcoholism, and the National Institute on Drug Abuse. She reported having no financial conflicts of interest.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

HBV/HIV coinfection a significant risk factor for inpatient mortality
MDedge Family Medicine
HIV patients with elevated ALT at significant risk of chronic liver disease
MDedge Family Medicine
Don’t underestimate opioid use in HIV-positive adults
MDedge Family Medicine
Early ART prevents HIV transmission to serodiscordant partner
MDedge Family Medicine
Dapivirine vaginal ring sharply reduces HIV infection risk
MDedge Family Medicine
Global HIV/AIDS mortality declines, but infection rate is unimproved
MDedge Family Medicine
Indiana HIV outbreak linked to injection use of oxymorphone
MDedge Family Medicine
HIV research update: Early July 2016
MDedge Family Medicine
Gay and bisexual male high schoolers have high injected drug use
MDedge Family Medicine
Psychiatric disorders often impair antiretroviral adherence in perinatally HIV-infected teens
MDedge Family Medicine